Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.

Mira A LankiHanna SeppänenHarri MustonenJaana HagströmCaj Haglund

Published in: PloS one (2019)

Strong TLR1 expression suggested better prognosis in PDAC patients, whereas negative expression of TLR1, TLR3, TLR7, or TLR9 was a sign of poor prognosis.

Keyphrases

toll like receptor
poor prognosis
inflammatory response
nuclear factor
immune response
long non coding rna
newly diagnosed
prognostic factors
binding protein